when to start art in adults? the results of hptn 052 move us closer to a test-and-treat policy
Clicks: 84
ID: 143367
2011
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
24.9
/100
84 views
4 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #60 of 77 articles by views in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
When is the best time to initiate antiretroviral therapy (ART) in adults? This is a vital question in HIV treatment and prevention services. More specifically, is the 350 cells/µl CD4 count threshold recommended by current World Health Organization (WHO) guidelines sufficient, or should we move to a ‘test-and-treat’ approach in which anyone who tests HIV-positive is offered ART, irrespective of their CD4 count? The recently announced results of the HPTN 052 trial take us closer, but not all the way, to a test-and-treat approach.
| Reference Key |
geffen2011southernwhen
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Nathan Geffen |
| Journal | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer |
| Year | 2011 |
| DOI |
10.4102/sajhivmed.v12i3.178
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.